These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 12015581

  • 1. Amyloid diseases: small drugs lead the attack.
    Iversen L.
    Nature; 2002 May 16; 417(6886):231-3. PubMed ID: 12015581
    [No Abstract] [Full Text] [Related]

  • 2. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
    Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN.
    Nature; 2002 May 16; 417(6886):254-9. PubMed ID: 12015594
    [Abstract] [Full Text] [Related]

  • 3. Drug targets for amyloidosis.
    Kolstoe SE, Wood SP.
    Biochem Soc Trans; 2010 Apr 16; 38(2):466-70. PubMed ID: 20298204
    [Abstract] [Full Text] [Related]

  • 4. Structure of pentameric human serum amyloid P component.
    Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, Tickle IJ, Blundell TL, Pepys MB, Wood SP.
    Nature; 1994 Jan 27; 367(6461):338-45. PubMed ID: 8114934
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
    Green NS, Palaninathan SK, Sacchettini JC, Kelly JW.
    J Am Chem Soc; 2003 Nov 05; 125(44):13404-14. PubMed ID: 14583036
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.
    Hohenester E, Hutchinson WL, Pepys MB, Wood SP.
    J Mol Biol; 1997 Jun 20; 269(4):570-8. PubMed ID: 9217261
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro.
    Urbányi Z, Forrai E, Sárvári M, Likó I, Illés J, Pázmány T.
    Neurochem Int; 2005 May 20; 46(6):471-7. PubMed ID: 15769549
    [Abstract] [Full Text] [Related]

  • 10. An entropically efficient supramolecular inhibition strategy for Shiga toxins.
    Kitov PI, Lipinski T, Paszkiewicz E, Solomon D, Sadowska JM, Grant GA, Mulvey GL, Kitova EN, Klassen JS, Armstrong GD, Bundle DR.
    Angew Chem Int Ed Engl; 2008 May 20; 47(4):672-6. PubMed ID: 18098248
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Novel therapeutic approach to amyloidosis: no implications as yet for patients with Alzheimer's disease].
    Lemstra AW, Eikelenboom P, Meijer EW, van Gool WA.
    Ned Tijdschr Geneeskd; 2002 Sep 14; 146(37):1720-3. PubMed ID: 12357871
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design of mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and new structural templates.
    Gupta S, Chhibber M, Sinha S, Surolia A.
    J Med Chem; 2007 Nov 15; 50(23):5589-99. PubMed ID: 17948976
    [Abstract] [Full Text] [Related]

  • 17. [Rheumatoid arthritis and secondary amyloidosis].
    Inada S.
    Ryumachi; 2000 Oct 15; 40(5):849-56. PubMed ID: 11215164
    [No Abstract] [Full Text] [Related]

  • 18. A genetically encoded diazirine photocrosslinker in Escherichia coli.
    Tippmann EM, Liu W, Summerer D, Mack AV, Schultz PG.
    Chembiochem; 2007 Dec 17; 8(18):2210-4. PubMed ID: 18000916
    [No Abstract] [Full Text] [Related]

  • 19. Use of genetically altered mice to study the role of serum amyloid P component in amyloid deposition.
    Maeda S.
    Amyloid; 2003 Aug 17; 10 Suppl 1():17-20. PubMed ID: 14640037
    [Abstract] [Full Text] [Related]

  • 20. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
    Cui D, Hoshii Y, Kawano H, Sugiyama S, Gondo T, Liu Y, Ishihara T.
    Int Immunopharmacol; 2007 Sep 17; 7(9):1232-40. PubMed ID: 17630202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.